Paper Details

  1. Home
  2. Paper Details

Adjunctive therapy in Parkinson's disease: the role of rasagiline.

Author: GainesKathryn D, HinsonVanessa K

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Rasagiline is an effective adjunctive therapy for Parkinson's disease, with benefits including improved motor function and delayed progression of the disease. It has been shown to reduce the need for levodopa and is generally well-tolerated.
Paper Details　
Original Abstract of the Article :
Parkinson's disease is the second most common neurodegenerative disorder, currently affecting 1.5 million people in the US. In this review, we describe the diagnostic and pathological features of Parkinson's disease, as well as its clinical course. We then review pharmacologic treatments for the dis...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395407/

データ提供：米国国立医学図書館（NLM）

Rasagiline: An Adjunctive Therapy for Parkinson's Disease

This research delves into the complex world of neurodegenerative diseases, focusing on Parkinson's disease and the potential benefits of rasagiline as an adjunctive therapy. Much like a wise camel navigating a treacherous desert path, rasagiline may play a supporting role in improving the lives of individuals struggling with Parkinson's. The authors provide a comprehensive overview of Parkinson's disease, its diagnosis, treatment options, and the role of rasagiline. This research is a valuable resource for healthcare professionals seeking to optimize treatment strategies for Parkinson's disease.

Rasagiline Shows Promise as an Adjunctive Therapy for Parkinson's Disease

This review highlights the potential benefits of rasagiline as an adjunctive therapy in Parkinson's disease. The authors analyze the results of four pivotal trials, demonstrating that rasagiline can improve motor function and reduce the need for levodopa, a key medication in Parkinson's management. This research provides a glimmer of hope for individuals seeking to manage their Parkinson's symptoms effectively.

Navigating the Desert of Parkinson's Disease

Parkinson's disease presents a challenging journey for individuals and their families. This research offers valuable insights into the potential benefits of rasagiline as an adjunctive therapy. By understanding the mechanisms of action and potential side effects of this medication, healthcare professionals can work with patients to develop personalized treatment plans that optimize their well-being.

Dr. Camel's Conclusion

Rasagiline holds promise as an adjunctive therapy for Parkinson's disease, potentially improving motor function and reducing the need for levodopa. This research provides valuable information for healthcare professionals to consider when developing individualized treatment plans for their patients with Parkinson's disease.

Date :
  1. Date Completed 2012-08-23
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

22802692

DOI: Digital Object Identifier

PMC3395407

Related Literature

Article Analysis
・Side Effects of rasagiline
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.